You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inverse Agonist

Showing 51 - 75 of 1,881
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Luteal Phase Support Trial in Jerusalem (GnRH agonist, hCG, Progesterone 100Mg Vag Tab)

Recruiting
  • Luteal Phase Support
  • GnRH agonist
  • +2 more
  • Jerusalem, Israel
    Shaare Zedek medical center
Apr 20, 2023

Endometriosis, Adenomyosis, Infertility, Female Trial in Suresnes (GnRH agonist)

Recruiting
  • Endometriosis
  • +2 more
  • GnRH agonist
  • Suresnes, France
    Hopital Foch
Aug 2, 2022

Healthy Trial in Merksem (Ponesimod, Carbamazepine)

Recruiting
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jan 31, 2023

Metastatic Uveal Melanoma in the Liver Trial in United States (SD-101, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Uveal Melanoma in the Liver
  • Los Angeles, California
  • +9 more
Jan 27, 2023

Gynecologic Cancer Trial in Saint Louis (Single digit pelvic exam)

Not yet recruiting
  • Gynecologic Cancer
  • Single digit pelvic exam
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 15, 2023

Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET/CT response evaluation
  • Utrecht, Netherlands
    Roderick van den Bergh
Sep 10, 2022

Cancer-Related Pain Trial in Philadelphia (Use of buprenorphine with FAO > 30 OME, CPM Rx application use)

Recruiting
  • Cancer-Related Pain
  • Use of buprenorphine with FAO > 30 OME
  • CPM Rx application use
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jun 9, 2023

Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)

Not yet recruiting
  • Intracytoplasmic Sperm Injection
  • +3 more
  • ultrashort GnRHa
  • +2 more
  • (no location specified)
Oct 2, 2022

Obesity, Overweight and Obesity, Overweight Trial (Tirzepatide)

Not yet recruiting
  • Obesity
  • +2 more
  • (no location specified)
Jun 21, 2023

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

Recruiting
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-JR11
  • Beijing, Beijing, China
  • +1 more
Jul 27, 2022

Cuff-tear Arthropathy Trial in Worldwide (Inverse/Reverse Shoulder Arthroplasty)

Active, not recruiting
  • Cuff-tear Arthropathy
  • Inverse/Reverse Shoulder Arthroplasty
  • Antwerpen, Belgium
  • +4 more
Feb 3, 2022

Parkinson Disease, Mild Cognitive Impairment Trial in Stavanger (AZD0328, Placebo)

Withdrawn
  • Parkinson Disease
  • Mild Cognitive Impairment
  • (no location specified)
Oct 11, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Postoperative Pain Trial in Kocaeli (Dexmedetomidine, Remifentanyl)

Completed
  • Postoperative Pain
  • Kocaeli, Izmit, Turkey
    University of Kocaeli
Mar 6, 2023

Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

Not yet recruiting
  • Gastrointestinal Cancer
  • +2 more
  • Miami, Florida
  • +1 more
Mar 6, 2023

Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2022

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Endometrial Hyperplasia Trial in Saint Louis (Semaglutide, Placebo, Progestin)

Not yet recruiting
  • Endometrial Hyperplasia
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 24, 2023

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Excessive Daytime Sleepiness, Obstructive Sleep Apnea Trial in Bulgaria, North Macedonia (Pitolisant (BF2.649), Placebo)

Completed
  • Excessive Daytime Sleepiness
  • Obstructive Sleep Apnea
  • Pitolisant (BF2.649)
  • Placebo
  • Burgas, Bulgaria
  • +5 more
Jul 7, 2020

NSCLC Trial in Worldwide (JTX-4014, Vopratelimab)

Active, not recruiting
  • NSCLC
  • Minsk, Belarus
  • +70 more
Jan 18, 2023

Depression, Unipolar, Treatment Resistant Depression Trial in Oxford (PF-04995274, Placebo Oral Tablet)

Completed
  • Depression, Unipolar
  • Treatment Resistant Depression
  • Oxford, Oxfordshire, United Kingdom
    University of Oxford
Nov 1, 2022

Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])

Recruiting
  • Obesity
  • Diabetes Type 2
  • Semaglutide Pen Injector [Ozempic]
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jul 29, 2022